ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 295466 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 295466; 2) Community: the network communities that were significantly associated with the response to NSC 295466; 3) Molecule: the relationships between components within communities and NSC 295466; 4) MDR: the compounds that were significantly associated with the NSC 295466.

NSC Compound Enrichment Correlation
NSC 664701 Null 0.00617256681787881 0.32230982
NSC 665533 Null 0.00617256681787881 0.14547715
NSC 672140 Null 0.00617256681787881 0.14120576
NSC 672304 Null 0.00617256681787881 0.00070018057
NSC 681972 Null 0.00617256681787881 0.15010836
NSC 693169 Null 0.00617256681787881 -0.051845479
NSC 718781 Erlotinib hydrochloride 0.00617256681787881 -0.19912191
NSC 719667 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one 0.00617256681787881 0.23501632
NSC 725098 Null 0.00617256681787881 0.13363086
NSC 732936 5,6-Dihydro-6-(3-dimethylamino-1-propyl)-2,3-methylenedioxy- 5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.00617256681787881 0.21000117
Total:164  Current:39    [First] [Prev] [Next] [Last]